Published in J Vasc Interv Radiol on October 01, 2005
Nanoparticle PEGylation for imaging and therapy. Nanomedicine (Lond) (2011) 3.33
Liposomal doxorubicin increases radiofrequency ablation-induced tumor destruction by increasing cellular oxidative and nitrative stress and accelerating apoptotic pathways. Radiology (2010) 1.84
Mathematical spatio-temporal model of drug delivery from low temperature sensitive liposomes during radiofrequency tumour ablation. Int J Hyperthermia (2010) 1.14
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev (2015) 1.08
Do liposomal apoptotic enhancers increase tumor coagulation and end-point survival in percutaneous radiofrequency ablation of tumors in a rat tumor model? Radiology (2010) 1.07
Nanoparticle preconditioning for enhanced thermal therapies in cancer. Nanomedicine (Lond) (2011) 1.03
[(186)Re]Liposomal doxorubicin (Doxil): in vitro stability, pharmacokinetics, imaging and biodistribution in a head and neck squamous cell carcinoma xenograft model. Nucl Med Biol (2009) 1.02
Phase I study of heat-deployed liposomal doxorubicin during radiofrequency ablation for hepatic malignancies. J Vasc Interv Radiol (2011) 1.02
Environmentally responsive peptides as anticancer drug carriers. Adv Drug Deliv Rev (2009) 1.01
Chemoradionuclide therapy with 186Re-labeled liposomal doxorubicin in combination with radiofrequency ablation for effective treatment of head and neck cancer in a nude rat tumor xenograft model. Radiology (2011) 0.98
Copper-doxorubicin as a nanoparticle cargo retains efficacy with minimal toxicity. Mol Pharm (2010) 0.97
Combination radiofrequency (RF) ablation and IV liposomal heat shock protein suppression: reduced tumor growth and increased animal endpoint survival in a small animal tumor model. J Control Release (2011) 0.93
Combination radiofrequency ablation and intravenous radiolabeled liposomal Doxorubicin: imaging and quantification of increased drug delivery to tumors. Radiology (2010) 0.90
Image-guided interventional therapy for cancer with radiotherapeutic nanoparticles. Adv Drug Deliv Rev (2014) 0.84
Preparation, characterization and pharmacokinetics of folate receptor-targeted liposomes for docetaxel delivery. J Nanosci Nanotechnol (2009) 0.84
Role of Pluronic block copolymers in modulation of heat shock protein 70 expression. Int J Hyperthermia (2011) 0.82
Adjuvant liposomal doxorubicin markedly affects radiofrequency ablation-induced effects on periablational microvasculature. J Vasc Interv Radiol (2013) 0.81
Novel approaches to treatment of hepatocellular carcinoma and hepatic metastases using thermal ablation and thermosensitive liposomes. Surg Oncol Clin N Am (2013) 0.79
Nanodrug-enhanced radiofrequency tumor ablation: effect of micellar or liposomal carrier on drug delivery and treatment efficacy. PLoS One (2014) 0.77
Enhancement of Intratumoral Chemotherapy with Cisplatin with or without Microwave Ablation and Lipiodol. Future Concept for Local Treatment in Lung Cancer. J Cancer (2015) 0.75
Radiofrequency ablation of small hepatocellular carcinoma with intravenous pegylated liposomal doxorubicin. Hepatol Int (2010) 0.75
Magnetic resonance imaging assessment of effective ablated volume following high intensity focused ultrasound. PLoS One (2015) 0.75
Current and future technology for minimally invasive ablation of renal cell carcinoma. Indian J Urol (2010) 0.75
Thermoresponsive Collagen/Cell Penetrating Hybrid Peptide as Nanocarrier in Targeting-Free Cell Selection and Uptake. Anal Chem (2016) 0.75
Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology (2003) 5.42
Peptide and protein drug delivery to and into tumors: challenges and solutions. Drug Discov Today (2003) 2.72
Principles of and advances in percutaneous ablation. Radiology (2011) 2.44
Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs. Proc Natl Acad Sci U S A (2003) 2.28
Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach". Cancer (2003) 2.22
Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up. Radiology (2012) 2.16
Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications. Radiographics (2004) 1.92
Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Radiology (2003) 1.85
Liposomal doxorubicin increases radiofrequency ablation-induced tumor destruction by increasing cellular oxidative and nitrative stress and accelerating apoptotic pathways. Radiology (2010) 1.84
Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. Radiology (2014) 1.78
Irreversible electroporation ablation: is all the damage nonthermal? Radiology (2012) 1.68
Colonic perforation at CT colonography: assessment of risk in a multicenter large cohort. Radiology (2006) 1.67
Small molecule inhibition of phosphatidylinositol-3,4,5-triphosphate (PIP3) binding to pleckstrin homology domains. Proc Natl Acad Sci U S A (2010) 1.61
Liposome clearance in mice: the effect of a separate and combined presence of surface charge and polymer coating. Int J Pharm (2002) 1.58
Optimal strategies for combining transcatheter arterial chemoembolization and radiofrequency ablation in rabbit VX2 hepatic tumors. J Vasc Interv Radiol (2008) 1.57
Radiofrequency ablation: modeling the enhanced temperature response to adjuvant NaCl pretreatment. Radiology (2004) 1.56
Microwave ablation: results with a 2.45-GHz applicator in ex vivo bovine and in vivo porcine liver. Radiology (2006) 1.54
Near-infrared fluorescence imaging of microcalcification in an animal model of breast cancer. Acad Radiol (2003) 1.49
Does arterial spin-labeling MR imaging-measured tumor perfusion correlate with renal cell cancer response to antiangiogenic therapy in a mouse model? Radiology (2009) 1.42
Radiofrequency ablation: importance of background tissue electrical conductivity--an agar phantom and computer modeling study. Radiology (2005) 1.34
Perfusion MDCT enables early detection of therapeutic response to antiangiogenic therapy. AJR Am J Roentgenol (2008) 1.33
Resistance of renal cell carcinoma to sorafenib is mediated by potentially reversible gene expression. PLoS One (2011) 1.32
Impact of CT-guided drainage in the treatment of diverticular abscesses: size matters. AJR Am J Roentgenol (2006) 1.26
Best practices in cancer nanotechnology: perspective from NCI nanotechnology alliance. Clin Cancer Res (2012) 1.24
Percutaneous saline-enhanced radiofrequency ablation of unresectable hepatic tumors: initial experience in 26 patients. AJR Am J Roentgenol (2003) 1.21
Radiofrequency thermal ablation sharply increases intratumoral liposomal doxorubicin accumulation and tumor coagulation. Cancer Res (2003) 1.19
Real-time US-CT/MRI image fusion for guidance of thermal ablation of liver tumors undetectable with US: results in 295 cases. Cardiovasc Intervent Radiol (2014) 1.19
Radiofrequency tumor ablation: insight into improved efficacy using computer modeling. AJR Am J Roentgenol (2005) 1.19
Radiofrequency ablation: effect of surrounding tissue composition on coagulation necrosis in a canine tumor model. Radiology (2004) 1.19
Radiofrequency ablation: the experts weigh in. Cancer (2004) 1.16
Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol (2007) 1.16
Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol (2009) 1.16
Percutaneous tumor ablation: increased necrosis with combined radio-frequency ablation and intravenous liposomal doxorubicin in a rat breast tumor model. Radiology (2002) 1.14
Improved tumor destruction with arsenic trioxide and radiofrequency ablation in three animal models. Radiology (2006) 1.13
Dynamic magnetic fields remote-control apoptosis via nanoparticle rotation. ACS Nano (2014) 1.13
Combination of radiofrequency ablation with antiangiogenic therapy for tumor ablation efficacy: study in mice. Radiology (2007) 1.13
Intracellular transduction using cell-penetrating peptides. Mol Biosyst (2009) 1.12
Radio-frequency ablation increases intratumoral liposomal doxorubicin accumulation in a rat breast tumor model. Radiology (2002) 1.11
Irreversible electroporation: treatment effect is susceptible to local environment and tissue properties. Radiology (2013) 1.11
Renal cancer resistance to antiangiogenic therapy is delayed by restoration of angiostatic signaling. Mol Cancer Ther (2010) 1.10
Characterization of the RF ablation-induced 'oven effect': the importance of background tissue thermal conductivity on tissue heating. Int J Hyperthermia (2006) 1.10
US findings after irreversible electroporation ablation: radiologic-pathologic correlation. Radiology (2011) 1.09
Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy. J Vasc Interv Radiol (2006) 1.08
Do liposomal apoptotic enhancers increase tumor coagulation and end-point survival in percutaneous radiofrequency ablation of tumors in a rat tumor model? Radiology (2010) 1.07
New ways of imaging uptake and intracellular fate of liposomal drug carrier systems inside individual cells, based on Raman microscopy. Mol Pharm (2008) 1.07
Society of Interventional Radiology position statement on percutaneous radiofrequency ablation for the treatment of liver tumors. J Vasc Interv Radiol (2009) 1.05
Immunoconjugates and long circulating systems: origins, current state of the art and future directions. Adv Drug Deliv Rev (2012) 1.05
High-power generator for radiofrequency ablation: larger electrodes and pulsing algorithms in bovine ex vivo and porcine in vivo settings. Radiology (2007) 1.05
Radiofrequency ablation combined with liposomal quercetin to increase tumour destruction by modulation of heat shock protein production in a small animal model. Int J Hyperthermia (2011) 1.05
Radiofrequency ablation: Effect of pharmacologic modulation of hepatic and renal blood flow on coagulation diameter in a VX2 tumor model. J Vasc Interv Radiol (2004) 1.03
Combination radiofrequency ablation with intratumoral liposomal doxorubicin: effect on drug accumulation and coagulation in multiple tissues and tumor types in animals. Radiology (2005) 1.02
Innovations and challenges in renal cancer: consensus statement from the first international conference. Clin Cancer Res (2004) 1.02
Thermal ablation therapy for hepatocellular carcinoma. J Vasc Interv Radiol (2002) 0.99
Liposome based systems for systemic siRNA delivery: stability in blood sets the requirements for optimal carrier design. J Control Release (2011) 0.98
Irreversible electroporation ablation: creation of large-volume ablation zones in in vivo porcine liver with four-electrode arrays. Radiology (2013) 0.97
Unresectable lung malignancy: combination therapy with segmental pulmonary arterial chemoembolization with drug-eluting microspheres and radiofrequency ablation in 17 patients. Radiology (2012) 0.97
Thermal ablation a comparison of thermal dose required for radiofrequency-, microwave-, and laser-induced coagulation in an ex vivo bovine liver model. Acad Radiol (2009) 0.97
Immediate renal tumor involution after radiofrequency thermal ablation. J Vasc Interv Radiol (2008) 0.95
Reduced tumor growth with combined radiofrequency ablation and radiation therapy in a rat breast tumor model. Radiology (2005) 0.95
Improved coagulation with saline solution pretreatment during radiofrequency tumor ablation in a canine model. J Vasc Interv Radiol (2002) 0.95
Radiofrequency ablation: variability in heat sensitivity in tumors and tissues. J Vasc Interv Radiol (2007) 0.95
Colonic perforation and abscess following radiofrequency ablation treatment of hepatoma. Eur J Ultrasound (2002) 0.94
ATP-containing immunoliposomes specific for cardiac myosin. Curr Drug Deliv (2004) 0.94
Radiofrequency ablation: the effect of distance and baseline temperature on thermal dose required for coagulation. Int J Hyperthermia (2008) 0.94
Synergy in cancer treatment between liposomal chemotherapeutics and thermal ablation. Chem Phys Lipids (2011) 0.93
Characterization of irreversible electroporation ablation in in vivo porcine liver. AJR Am J Roentgenol (2012) 0.93
Combination radiofrequency (RF) ablation and IV liposomal heat shock protein suppression: reduced tumor growth and increased animal endpoint survival in a small animal tumor model. J Control Release (2011) 0.93
Computer modeling of the combined effects of perfusion, electrical conductivity, and thermal conductivity on tissue heating patterns in radiofrequency tumor ablation. Int J Hyperthermia (2008) 0.93
Radio-frequency tumor ablation: internally cooled electrode versus saline-enhanced technique in an aggressive rabbit tumor model. Radiology (2002) 0.92
Electromagnetic navigation system for CT-guided biopsy of small lesions. AJR Am J Roentgenol (2011) 0.92
Stable nanocolloids of poorly soluble drugs with high drug content prepared using the combination of sonication and layer-by-layer technology. J Control Release (2008) 0.92
Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy. J Vasc Interv Radiol (2009) 0.92
Multi-detector row CT of relevant vascular anatomy of the surgical plane in split-liver transplantation. Radiology (2003) 0.91
Percutaneous tumor ablation: reduced tumor growth with combined radio-frequency ablation and liposomal doxorubicin in a rat breast tumor model. Radiology (2003) 0.91
Review of radiofrequency ablation for renal cell carcinoma. Clin Cancer Res (2004) 0.91
Organized shells on clay nanotubes for controlled release of macromolecules. Macromol Rapid Commun (2008) 0.91
Interaction of gadolinium-based MR contrast agents with choline: implications for MR spectroscopy (MRS) of the breast. Magn Reson Med (2009) 0.90
Hybrid radiofrequency and cryoablation device: preliminary results in an animal model. J Vasc Interv Radiol (2004) 0.90
Converting poorly soluble materials into stable aqueous nanocolloids. Langmuir (2010) 0.89
Structure-activity relationships, kinetics, selectivity, and mechanistic studies of synthetic hydraphile channels in bacterial and mammalian cells. Org Biomol Chem (2005) 0.89
Acute appendicitis: effect of increased use of CT on selecting patients earlier. Radiology (2003) 0.89
CT perfusion for determination of pharmacologically mediated blood flow changes in an animal tumor model. Radiology (2007) 0.87
High dose intermittent sorafenib shows improved efficacy over conventional continuous dose in renal cell carcinoma. J Transl Med (2011) 0.87
Research reporting standards for image-guided ablation of bone and soft tissue tumors. J Vasc Interv Radiol (2009) 0.87
Improving microcirculation is more effective than substitution of red blood cells to correct metabolic disorder in experimental hemorrhagic shock. Shock (2004) 0.87
Quality initiatives: strategies for anticipating and reducing complications and treatment failures in hepatic radiofrequency ablation. Radiographics (2010) 0.86
Society of Interventional Radiology position statement on percutaneous radiofrequency ablation for the treatment of liver tumors. J Vasc Interv Radiol (2008) 0.86
In vitro cytotoxicity of novel pro-apoptotic agent DM-PIT-1 in PEG-PE-based micelles alone and in combination with TRAIL. Drug Deliv (2009) 0.85
Quantum dots encapsulated in phospholipid micelles for imaging and quantification of tumors in the near-infrared region. Nanomedicine (2009) 0.85
Image-guided percutaneous chemical and radiofrequency tumor ablation in an animal model. J Vasc Interv Radiol (2003) 0.85
Body tumor CT perfusion protocols: optimization of acquisition scan parameters in a rat tumor model. Radiology (2009) 0.84
Chemical tumor ablation with use of a novel multiple-tine infusion system in a canine sarcoma model. J Vasc Interv Radiol (2006) 0.84
Efficacy of radiofrequency ablation in the treatment of small functional adrenal neoplasms. Radiology (2010) 0.83
Photodynamic therapy of experimental B-16 melanoma in mice with tumor-targeted 5,10,15,20-tetraphenylporphin-loaded PEG-PE micelles. J Drug Target (2008) 0.83
Basic science research in thermal ablation. Surg Oncol Clin N Am (2011) 0.82